Validated genomic approach to study differentially expressed genes in complex tissues.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 12462402)

Published in Neurochem Res on October 01, 2002

Authors

Elisa Wurmbach1, Javier González-Maeso, Tony Yuen, Barbara J Ebersole, Jason W Mastaitis, Charles V Mobbs, Stuart C Sealfon

Author Affiliations

1: Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA.

Articles by these authors

Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res (2002) 6.70

Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature (2008) 4.09

Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat Med (2011) 3.09

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron (2007) 2.98

Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol (2006) 2.94

Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci U S A (2007) 2.59

Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J (2004) 2.56

Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell (2011) 2.55

Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science (2006) 2.49

Local protein synthesis mediates a rapid increase in dendritic elongation factor 1A after induction of late long-term potentiation. J Neurosci (2005) 2.00

Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. J Clin Invest (2012) 1.77

Focused microarray analysis. Methods (2003) 1.73

Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J Neurosci (2003) 1.64

Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes. Proc Natl Acad Sci U S A (2013) 1.54

flowPeaks: a fast unsupervised clustering for flow cytometry data via K-means and density peak finding. Bioinformatics (2012) 1.53

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci (2012) 1.52

Differential gene expression in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2011) 1.48

Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neurosci (2002) 1.44

Monitoring G-protein-coupled receptor signaling with DNA microarrays and real-time polymerase chain reaction. Methods Enzymol (2002) 1.41

Chromosome-specific and noisy IFNB1 transcription in individual virus-infected human primary dendritic cells. Nucleic Acids Res (2007) 1.40

Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring. J Neurosci (2011) 1.36

Psychedelics and schizophrenia. Trends Neurosci (2009) 1.32

Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog (2008) 1.32

Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A (2013) 1.31

CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain (2005) 1.30

Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia. Proc Natl Acad Sci U S A (2013) 1.28

Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress. J Biol Chem (2004) 1.24

VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting. J Neurosci (2002) 1.22

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists. Neurosci Lett (2011) 1.21

Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. J Biol Chem (2003) 1.18

Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia. Proc Natl Acad Sci U S A (2013) 1.17

Improved compensation in flow cytometry by multivariable optimization. Cytometry A (2011) 1.15

VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Endocrinology (2005) 1.15

Getting started in biological pathway construction and analysis. PLoS Comput Biol (2008) 1.14

Chronic exposure to TNF-alpha increases airway mucus gene expression in vivo. J Allergy Clin Immunol (2005) 1.13

Misty Mountain clustering: application to fast unsupervised flow cytometry gating. BMC Bioinformatics (2010) 1.13

Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes (2003) 1.12

Method for multiplex cellular detection of mRNAs using quantum dot fluorescent in situ hybridization. Nucleic Acids Res (2005) 1.12

Biphasic effects of postnatal exposure to diethylhexylphthalate on the timing of puberty in male rats. J Androl (2007) 1.11

Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats. Diabetes (2003) 1.11

Antiviral response dictated by choreographed cascade of transcription factors. J Immunol (2010) 1.10

Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling. PLoS Biol (2009) 1.10

Multiple testing and its applications to microarrays. Stat Methods Med Res (2009) 1.10

Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab (2014) 1.09

Research resource: Gonadotropin-releasing hormone receptor-mediated signaling network in LbetaT2 cells: a pathway-based web-accessible knowledgebase. Mol Endocrinol (2010) 1.09

Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. Identification of a novel "locked-on" phenotype and double revertant mutations. J Biol Chem (2002) 1.05

SOD isoforms play no role in lifespan in ad lib or dietary restricted conditions, but mutational inactivation of SOD-1 reduces life extension by cold. Mech Ageing Dev (2008) 1.05

Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton. J Biol Chem (2012) 1.05

Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone beta subunit transcription. J Mol Endocrinol (2007) 1.04

Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes (2004) 1.04

Mixed analog/digital gonadotrope biosynthetic response to gonadotropin-releasing hormone. J Biol Chem (2006) 1.04

Group II metabotropic glutamate receptors and schizophrenia. Cell Mol Life Sci (2009) 1.04

Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis. Proc Natl Acad Sci U S A (2012) 1.04

Hypothalamic responses to fasting indicate metabolic reprogramming away from glycolysis toward lipid oxidation. Endocrinology (2010) 1.03

Animal models of serotonergic psychedelics. ACS Chem Neurosci (2012) 1.03

Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption. FASEB J (2003) 1.03

Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation. J Biol Chem (2012) 1.03

Gaucher disease gene GBA functions in immune regulation. Proc Natl Acad Sci U S A (2012) 1.02

Transcript profiling of immediate early genes reveals a unique role for activating transcription factor 3 in mediating activation of the glycoprotein hormone alpha-subunit promoter by gonadotropin-releasing hormone. Mol Endocrinol (2005) 1.02

Time and length scales of autocrine signals in three dimensions. Biophys J (2007) 1.01

Role of glucocorticoids in mediating effects of fasting and diabetes on hypothalamic gene expression. BMC Physiol (2003) 1.00

The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest (2006) 1.00

Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function. J Biol Chem (2012) 1.00

Role of cell-to-cell variability in activating a positive feedback antiviral response in human dendritic cells. PLoS One (2011) 1.00

Agonist-trafficking and hallucinogens. Curr Med Chem (2009) 1.00

Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia. Diabetes (2005) 1.00

p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J Biol Chem (2006) 0.99

Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts. Biochem Biophys Res Commun (2011) 0.99

Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors. Neuropharmacology (2011) 0.99

Structure of the GnRH receptor-stimulated signaling network: insights from genomics. Front Neuroendocrinol (2003) 0.98

BioPP: a tool for web-publication of biological networks. BMC Bioinformatics (2007) 0.98

Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines. Biochem J (2003) 0.97

Reversal of diabetic nephropathy by a ketogenic diet. PLoS One (2011) 0.96

Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of metabolic reprogramming in counterregulatory failure. Diabetes (2010) 0.96

Coupling of GnRH concentration and the GnRH receptor-activated gene program. Mol Endocrinol (2002) 0.95